S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$80,787.67
▼ -291.96 (-0.36%)
--:--:--
NYSE · Live ET

KYTX (KYTX)

5.39-0.34 (-5.93%)USD · · delayed · updates about every minute

Key statistics

Previous close
5.73
Day range
5.36 – 5.68
52-week low
5.61
52-week high
13.67
Volume
—
Type
—
52-WEEK RANGE POSITION

KYTX news

TradingViewKyverna Therapeutics, Inc. Estimates – NASDAQ:KYTX9h agoMoomooH.C. Wainwright Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Maintains Target Price $251d agoQuiver QuantitativeKyverna Therapeutics Reports Durable Clinical Benefit and CNS Penetration With Miv-Cel in Progressive Multiple Sclerosis1d agoStock TitanA patient with progressive MS had sustained clinical benefit beyond two years after one dose.1d agoInvesting.com NigeriaH.C. Wainwright reiterates Kyverna stock rating on full-year data By Investing.com2d agoYahoo! Finance CanadaKyverna Therapeutics, Inc. (KYTX) Stock Price, News, Quote & History2d agoQuiver QuantitativeKyverna Therapeutics Reports One-Year Durability Data for Miv-cel in Stiff Person Syndrome from KYSA-8 Trial4d agoStock TitanKyverna SPS trial shows 49% median walk gain at one year | KYTX Stock News4d ago

Learn to invest

The Psychology of Money
Morgan Housel · Beginner
The Little Book of Common Sense Investing
John C. Bogle · Beginner
The Intelligent Investor
Benjamin Graham · Intermediate